Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $6.1800 (3.78%) ($5.8200 - $6.2300) on Thu. Aug. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.54% (three month average) | RSI | 46 | Latest Price | $6.1800(3.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -5.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -15.2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IGOV(27%) TLT(23%) BWX(18%) TIP(17%) VCIT(17%) | Factors Impacting CAPR price | CAPR will decline at least -4.27% in a week (0% probabilities). XLB(-31%) URA(-30%) PAVE(-27%) XOP(-24%) XLI(-24%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.27% (StdDev 8.54%) | Hourly BBV | -2.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $7.27 | 5 Day Moving Average | $6.29(-1.75%) | 10 Day Moving Average | $7.08(-12.71%) | 20 Day Moving Average | $7.27(-14.99%) | To recent high | -37% | To recent low | 23.4% | Market Cap | $122m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |